Our translational research services

immuno-oncology target validation CRO cancer immunotherapy

Target identification & validation using preclinical & clinical samples

  • Tissues & liquid samples provided by the sponsor or acquired by Explicyte
  • Fit-for-purpose technology platforms, including digital pathology, bulk & spatial transcriptomics, FACS, …
  • Expertise in bioinformatics to make the most of your dataset
preclinical anti tumor immune profiling CRO in vivo mechanism action

Preclinical profiling for mechanism of action studies

  • Samples obtained from our in vivo platform or provided by the sponsor
  • Flexible sample collection with tumor biopsies & microdialysis, plasma & sera, organs, …
  • Validated approaches to detect tumor microenvironment (TME) markers & development of custom panels to highlight target of interest
biomarker research testing services clinical tumor samples CRO patient specimens

Biomarker research & biomarker testing in clinical samples

  • Large capacities to process and analyze patient samples from clinical trials & retrospective studies
  • Solid track record in biomarkers studies >20,000 patient samples already analyzed

Why working with Explicyte?

in Immuno-Oncology

  • A comprehensive platform to generate robust datasets
  • Over 10 years of experience in TME & peripheral marker profiling
  • 25+ peer-reviewed publications in high-impact immuno-oncology journals


  • Scientific interactions to discuss your project needs (e.g. nature of samples, biomarker panels, etc.)
  • A dedicated study director (PhD) from experimental plan to final report discussion
  • Development & validation of custom panels

Your contacts

explicyte team 2024

Talk to our team !

Paul Marteau, PharmD (preclinical study director), Imane Nafia, PhD (CSO), Loïc Cerf, MSc (COO), Alban Bessede, PhD (founder, CEO), Jean-Philippe Guégan, PhD (translational study director)

Tell us about your project !

    Select department:

    WordPress Lightbox